» Articles » PMID: 28285391

Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood During Hypoxemic COPD Exacerbations and Pulmonary Hypertension

Overview
Publisher Springer
Specialty Cell Biology
Date 2017 Mar 13
PMID 28285391
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Very small embryonic-like stem cells (VSELs) are major pluripotent stem cells involved in vascular and tissue regeneration and constitute a recruitable pool of stem/progenitor cells with putative instrumental role in organ repair. Here, we hypothesized that VSELs might be mobilized from the bone marrow (BM) to peripheral blood (PB) in patients with hypoxic lung disease or pulmonary hypertension (PH). The objective of the present study was then to investigate the changes in VSELs number in peripheral blood of patients with hypoxic lung disease and PH. We enrolled 26 patients with Chronic Obstructive Pulmonary Disease (COPD) with or without hypoxemia, 13 patients with PH and 20 controls without any respiratory or cardiovascular diseases. In PH patients, VSELs levels have been determined during right heart catheterization in pulmonary blood and PB. For this purpose, mononuclear cells were separated by density gradient and VSELs have been quantified by using a multiparametric flow cytometry approach. The number of PB-VSELs in hypoxic COPD patients was significantly increased compared with non-hypoxic COPD patients or controls (p = 0.0055). In patients with PH, we did not find any difference in VSELs numbers between arterial pulmonary blood and venous PB (p = 0.93). However, we found an increase in VSELs in the peripheral blood of patients with PH (p = 0.03). In conclusion, we unraveled that circulating VSELs were increased in peripheral blood of patients with hypoxic COPD or with PH. Thus, VSELs may serve as a reservoir of pluripotent stem cells that can be recruited into PB and may play an important role in promoting lung repair.

Citing Articles

Standardisation is the key to the sustained, rapid and healthy development of stem cell-based therapy.

Zhang J, Suo M, Wang J, Liu X, Huang H, Wang K Clin Transl Med. 2024; 14(4):e1646.

PMID: 38572666 PMC: 10993161. DOI: 10.1002/ctm2.1646.


Industrialized GMP Production of CD34 Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe.

Henon P, Kowalczyk M, Aries A, Vignon C, Trebuchet G, Lahlil R Stem Cell Rev Rep. 2022; 18(5):1614-1626.

PMID: 35420389 PMC: 9209364. DOI: 10.1007/s12015-022-10373-5.


Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells.

Lahlil R, Scrofani M, Aries A, Henon P, Drenou B Biology (Basel). 2021; 10(4).

PMID: 33918035 PMC: 8070267. DOI: 10.3390/biology10040312.


Is COVID-19 a New Hematologic Disease?.

Debuc B, Smadja D Stem Cell Rev Rep. 2020; 17(1):4-8.

PMID: 32399806 PMC: 7217340. DOI: 10.1007/s12015-020-09987-4.


Role of Adult Tissue-Derived Pluripotent Stem Cells in Bone Regeneration.

Leppik L, Sielatycka K, Henrich D, Han Z, Wang H, Eischen-Loges M Stem Cell Rev Rep. 2019; 16(1):198-211.

PMID: 31828580 PMC: 6987071. DOI: 10.1007/s12015-019-09943-x.


References
1.
Shin D, Zuba-Surma E, Wu W, Ratajczak J, Wysoczynski M, Ratajczak M . Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells. Leukemia. 2009; 23(11):2042-51. PMC: 2783188. DOI: 10.1038/leu.2009.153. View

2.
Ikonomou L, Freishtat R, Wagner D, Panoskaltsis-Mortari A, Weiss D . The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases. Professional Societies Need to Act. Ann Am Thorac Soc. 2016; 13(8):1205-7. DOI: 10.1513/AnnalsATS.201604-277ED. View

3.
Kucia M, Zuba-Surma E, Wysoczynski M, Wu W, Ratajczak J, Machalinski B . Adult marrow-derived very small embryonic-like stem cells and tissue engineering. Expert Opin Biol Ther. 2007; 7(10):1499-514. DOI: 10.1517/14712598.7.10.1499. View

4.
Shaikh A, Anand S, Kapoor S, Ganguly R, Bhartiya D . Mouse Bone Marrow VSELs Exhibit Differentiation into Three Embryonic Germ Lineages and Germ & Hematopoietic Cells in Culture. Stem Cell Rev Rep. 2017; 13(2):202-216. DOI: 10.1007/s12015-016-9714-0. View

5.
Starzynska T, Dabkowski K, Blogowski W, Zuba-Surma E, Budkowska M, Salata D . An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer. J Cell Mol Med. 2013; 17(6):792-9. PMC: 3823183. DOI: 10.1111/jcmm.12065. View